Shank3 regulates striatal synaptic abundance of Cyld, a deubiquitinase specific for Lys63‐linked polyubiquitin chains

The SH3 and multiple ankyrin repeat domains 3 (Shank3) proteins are core organizers of the postsynaptic density in neuronal excitatory synapses, and their defects cause various neurodevelopmental and neuropsychiatric disorders. Mechanistically, Shank3 directly and indirectly interacts with hundreds of synaptic proteins with diverse functions and potentially exerts its regulatory roles in synaptic development and function via these interactors. However, Shank3‐dependent regulation of synaptic abundance has been validated in vivo for only a few Shank3 interactors. Here, using a quantitative proteomic analysis, we identified 136 proteins with altered synaptic abundance in the striatum of Shank3‐overexpressing transgenic (TG) mice. By comparing these proteins with those found in a previous analysis of the postsynaptic density of Shank3 knock‐out (KO) striatum, we identified and confirmed that cylindromatosis‐associated deubiquitinase (Cyld), a deubiquitinase specific for Lys63‐linked polyubiquitin chains, was up‐ and down‐regulated in Shank3 TG and KO striatal synapses, respectively. Consistently, we found that the synaptic levels of Lys63‐linked polyubiquitin chains were down‐ and up‐regulated in the Shank3 TG and KO striata, respectively. Furthermore, by isolating and analyzing the synaptic Cyld complex, we generated a Cyld interactome consisting of 103 proteins, which may include Cyld substrates. Bioinformatic analyses suggested associations of the Cyld interactome with a few brain disorders and synaptic functions. Taken together, these results suggest that Shank3 regulates the synaptic abundance of Cyld in the mouse striatum and, thereby, potentially modulates the Lys63‐linked polyubiquitination of striatal synaptic proteins.

[1]  H. Zoghbi,et al.  An autism-linked missense mutation in SHANK3 reveals the modularity of Shank3 function , 2019, Molecular Psychiatry.

[2]  Bokyoung Lee,et al.  Smaller Body Size, Early Postnatal Lethality, and Cortical Extracellular Matrix-Related Gene Expression Changes of Cyfip2-Null Embryonic Mice , 2019, Front. Mol. Neurosci..

[3]  Kihoon Han,et al.  Emerging roles of Lys63-linked polyubiquitination in neuronal excitatory postsynapses , 2018, Archives of pharmacal research.

[4]  Kihoon Han,et al.  Spontaneous seizure and partial lethality of juvenile Shank3-overexpressing mice in C57BL/6 J background , 2018, Molecular Brain.

[5]  Kihoon Han,et al.  Excitatory and inhibitory synaptic dysfunction in mania: an emerging hypothesis from animal model studies , 2018, Experimental & Molecular Medicine.

[6]  Hyo Min Cho,et al.  Characterization of the zinc-induced Shank3 interactome of mouse synaptosome. , 2017, Biochemical and biophysical research communications.

[7]  V. Anggono,et al.  Regulation of AMPA Receptor Trafficking by Protein Ubiquitination , 2017, Front. Mol. Neurosci..

[8]  Hongyu Ruan,et al.  Proteasome-independent polyubiquitin linkage regulates synapse scaffolding, efficacy, and plasticity , 2017, Proceedings of the National Academy of Sciences.

[9]  Sun Gyun Kim,et al.  Striatal Transcriptome and Interactome Analysis of Shank3-overexpressing Mice Reveals the Connectivity between Shank3 and mTORC1 Signaling , 2017, Front. Mol. Neurosci..

[10]  Bokyoung Lee,et al.  Age-dependent decrease of GAD65/67 mRNAs but normal densities of GABAergic interneurons in the brain regions of Shank3-overexpressing manic mouse model , 2017, Neuroscience Letters.

[11]  Bokyoung Lee,et al.  Integrative Analysis of Brain Region-specific Shank3 Interactomes for Understanding the Heterogeneity of Neuronal Pathophysiology Related to SHANK3 Mutations , 2017, Front. Mol. Neurosci..

[12]  S. Tenzer,et al.  Proteomic Analysis of Post-synaptic Density Fractions from Shank3 Mutant Mice Reveals Brain Region Specific Changes Relevant to Autism Spectrum Disorder , 2017, Front. Mol. Neurosci..

[13]  G. Feng,et al.  SHANK proteins: roles at the synapse and in autism spectrum disorder , 2017, Nature Reviews Neuroscience.

[14]  Núria Queralt-Rosinach,et al.  DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..

[15]  Bokyoung Lee,et al.  Bipolar Disorder Associated microRNA, miR-1908-5p, Regulates the Expression of Genes Functioning in Neuronal Glutamatergic Synapses , 2016, Experimental neurobiology.

[16]  R. Weinberg,et al.  The Postsynaptic Density: There Is More than Meets the Eye , 2016, Front. Synaptic Neurosci..

[17]  Matthias Mann,et al.  Cell type– and brain region–resolved mouse brain proteome , 2015, Nature Neuroscience.

[18]  Laura Inés Furlong,et al.  PsyGeNET: a knowledge platform on psychiatric disorders and their genes , 2015, Bioinform..

[19]  G. Evans.  Subcellular fractionation of the brain: preparation of synaptosomes and synaptic vesicles. , 2015, Cold Spring Harbor protocols.

[20]  H. Zoghbi,et al.  Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice. , 2015, Human molecular genetics.

[21]  K. Bayer,et al.  IKK regulates the deubiquitinase CYLD at the postsynaptic density. , 2014, Biochemical and biophysical research communications.

[22]  T. Reese,et al.  CaMKII Mediates Recruitment and Activation of the Deubiquitinase CYLD at the Postsynaptic Density , 2014, PloS one.

[23]  Thomas Bourgeron,et al.  The emerging role of SHANK genes in neuropsychiatric disorders , 2014, Developmental neurobiology.

[24]  A. Breman,et al.  SHANK3 overexpression causes manic-like behavior with unique pharmacogenetic properties , 2013, Nature.

[25]  T. Ball,et al.  High pH reversed‐phase chromatography as a superior fractionation scheme compared to off‐gel isoelectric focusing for complex proteome analysis , 2013, Proteomics.

[26]  S. Gygi,et al.  Why do cellular proteins linked to K63‐polyubiquitin chains not associate with proteasomes? , 2013, The EMBO journal.

[27]  Yanji Xu,et al.  Synaptic protein ubiquitination in rat brain revealed by antibody-based ubiquitome analysis. , 2012, Journal of proteome research.

[28]  David Komander,et al.  Atypical ubiquitylation — the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages , 2012, Nature Reviews Molecular Cell Biology.

[29]  M. Rapé,et al.  The Ubiquitin Code , 2012, Annual review of biochemistry.

[30]  Daniel B. McClatchy,et al.  Characterization of breast cancer interstitial fluids by TmT labeling, LTQ-Orbitrap Velos mass spectrometry, and pathway analysis. , 2012, Journal of proteome research.

[31]  Anne-Marie Le Sourd,et al.  Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2 , 2012, Nature.

[32]  V. Lang,et al.  Isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. , 2012, Methods in molecular biology.

[33]  M. Sheng,et al.  The postsynaptic organization of synapses. , 2011, Cold Spring Harbor perspectives in biology.

[34]  T. Boeckers,et al.  Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. , 2011, Trends in cell biology.

[35]  D. Licatalosi,et al.  FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.

[36]  G. Feng,et al.  Shank3 mutant mice display autistic-like behaviours and striatal dysfunction , 2011, Nature.

[37]  Ramin Massoumi,et al.  Ubiquitin chain cleavage: CYLD at work. , 2010, Trends in biochemical sciences.

[38]  J. Hell.  Faculty Opinions recommendation of Autophosphorylated CaMKIIalpha acts as a scaffold to recruit proteasomes to dendritic spines. , 2010 .

[39]  M. Sheng,et al.  Autophosphorylated CaMKIIα Acts as a Scaffold to Recruit Proteasomes to Dendritic Spines , 2010, Cell.

[40]  S-C Sun.  CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes , 2010, Cell Death and Differentiation.

[41]  M. Sheng,et al.  Regulated RalBP1 Binding to RalA and PSD-95 Controls AMPA Receptor Endocytosis and LTD , 2009, PLoS biology.

[42]  V. Barbosa,et al.  YADA: a tool for taking the most out of high-resolution spectra , 2009, Bioinform..

[43]  S. Gygi,et al.  Defining the Human Deubiquitinating Enzyme Interaction Landscape , 2009, Cell.

[44]  Hwan‐Ching Tai,et al.  Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction , 2008, Nature Reviews Neuroscience.

[45]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[46]  Douglas J Slotta,et al.  Composition of the Synaptic PSD-95 Complex*S , 2007, Molecular & Cellular Proteomics.

[47]  C. Hoogenraad,et al.  The postsynaptic architecture of excitatory synapses: a more quantitative view. , 2007, Annual review of biochemistry.

[48]  S. Elledge,et al.  The tumor suppressor CYLD regulates entry into mitosis , 2007, Proceedings of the National Academy of Sciences.

[49]  S. Grant,et al.  Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome , 2006, Journal of neurochemistry.

[50]  R. Weinberg,et al.  Regulation of Dendritic Spine Morphogenesis by Insulin Receptor Substrate 53, a Downstream Effector of Rac1 and Cdc42 Small GTPases , 2005, The Journal of Neuroscience.

[51]  Steven P Gygi,et al.  Semiquantitative Proteomic Analysis of Rat Forebrain Postsynaptic Density Fractions by Mass Spectrometry* , 2004, Journal of Biological Chemistry.

[52]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[53]  M. Ehlers.  Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system , 2003, Nature Neuroscience.

[54]  J. Yates,et al.  DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. , 2002, Journal of proteome research.

[55]  A. Ashworth,et al.  Identification of the familial cylindromatosis tumour-suppressor gene , 2000, Nature Genetics.